3 unstoppable ASX shares to buy and hold for the next decade

These shares are going places over the remainder of the decade and beyond.

| More on:
A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When it comes to building long-term wealth in the share market, few strategies are as powerful as identifying quality ASX shares and simply holding them for the long haul.

While markets rise and fall, great companies tend to keep growing over time — rewarding patient investors handsomely.

With that in mind, here are three unstoppable ASX shares that could have the potential to deliver outstanding returns over the next decade.

Goodman Group (ASX: GMG)

The first ASX share to buy and hold could be Goodman. It is a global leader in industrial property, developing and managing logistics warehouses, data centres, and last-mile distribution facilities.

Goodman has made a name for itself by partnering with some of the biggest names in e-commerce and cloud computing, including Amazon and Microsoft. As demand for logistics and digital infrastructure continues to rise, Goodman's development pipeline and global footprint put it in an enviable position.

It is also betting big on data centres, which are in demand due to the cloud computing and artificial intelligence megatrends. Overall, it is riding powerful secular tailwinds that make it a long-term standout.

Pro Medicus Ltd (ASX: PME)

Another unstoppable ASX share that could be a buy is Pro Medicus. It has quietly become one of Australia's most successful tech exports. The company develops high-performance medical imaging software used by some of the world's top hospitals and research institutions.

Its flagship product, Visage, helps radiologists read images faster and more accurately, and demand continues to grow as healthcare systems modernise. Importantly, Pro Medicus operates on a highly scalable, software-as-a-service (SaaS) model with exceptional profit margins.

With a robust sales pipeline, long-term partnerships, and the increasing importance of AI-driven diagnostics, Pro Medicus is in a sweet spot to continue compounding its earnings well into the future.

Xero Ltd (ASX: XRO)

Finally, Xero could be an ASX share to buy for the long term. It has transformed from a New Zealand startup into a global leader in cloud accounting software. Its intuitive platform is used by 4.4 million small businesses and accountants across the globe.

What makes Xero so compelling is the sticky nature of its business. Once a small business is integrated into Xero's ecosystem, they are unlikely to leave. That recurring revenue model, combined with ongoing international expansion, especially in the US and UK, positions Xero for sustained growth in a market estimated to be 100 million small to medium sized businesses.

Over the next decade, as more businesses move away from legacy software and embrace digital solutions, Xero stands to be one of the biggest beneficiaries.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Motley Fool contributor James Mickleboro has positions in Goodman Group, Pro Medicus, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon, Goodman Group, Microsoft, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus and has recommended the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Amazon, Goodman Group, Microsoft, and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

woman looking at iPhone whilst working on a laptop
Growth Shares

3 of the best Australian shares to buy and hold until 2035

It could be worth holding tightly to these shares for the long term.

Read more »

Two large bulls fight against each other in the dust.
Growth Shares

2 quality ASX 200 stocks to buy for your 2026 portfolio

Brokers are bullish on these mainstay sector picks.

Read more »

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Growth Shares

Analysts say these ASX 200 shares could rise 30% to 40%

Big returns could be on offer with these growing stocks.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Man pointing at a blue rising share price graph.
Growth Shares

The 3 biggest ASX multibaggers in 2025

These billion-dollar ASX companies have delivered eye-catching multibagger returns in 2025.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These world class ASX 200 growth shares could rise 40% to 80%

These high-quality shares are seriously undervalued according to brokers.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

3 ASX mid-cap rockets that could become future blue chips

These stocks could be destined for big things in the future according to analysts.

Read more »